Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
810.00    2.00 (0.25%)
Bid:
809.00
Ask:
811.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2019 10:04

RNS Number : 3697Y
Savills PLC
08 May 2019
Β 

Β 

8 May 2019

SAVILLS PLC

("Savills" or "the Company")

AGM Statement

Β 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

Β 

During the year to date the Group has traded in line with our expectations. Globally, our transaction businesses have continued to maintain strong market shares although, as anticipated, volumes in certain markets have been subdued as a result of political and economic uncertainty. Our Consultancy, Property Management and Investment Management businesses have continued to perform well.

Β 

In the UK, trading has been resilient despite increased political uncertainty. In our Residential Transaction business there has been a healthy increase in indicators which are normally a precursor to increased market activity. Of particular note is strong double digit increases in new buyers registered and a year-on-year increase in revenue in the prime Central London market. The Commercial Transaction business is also proving resilient, particularly in Central London, however, volumes across the UK have declined and development activity is relatively subdued.

Β 

In Asia Pacific, Savills has had a good start to the year, with Hong Kong, Mainland China, Singapore and Vietnam showing year-on-year revenue growth.

Β 

In North America, the business has successfully rebranded to Savills and continued its strong revenue performance from Q4 2018 through the period, with corporates generally active in relatively benign market conditions. The New York, Washington and Californian markets have proved particularly active to date.

Β 

In Continental Europe and the Middle East, we have traded in line with our expectations, with good year-on-year revenue growth in Ireland, France, the Netherlands and the Czech Republic. In Sweden, the new Capital markets and leadership team have started well accumulating a strong pipeline of potential transaction activity for the second half of the year.

Β 

Savills Investment Management has performed as expected. As previously announced, we successfully concluded the search for a new CEO for Savills Investment Management , with Alex Jeffrey due to join the firm later in the year.

Β 

Whilst the year has started as expected, the first few months typically represent a relatively modest proportion of the expected outturn for the full year. In the UK market, there remains significant investor demand but commercial transaction activity in the next few months may continue to be overshadowed by the prolonged uncertainty over Brexit, the exact impact of which is difficult to determine at present. We do, however, expect some strengthening of activity in certain overseas markets and, despite a greater weighting towards H2 than last year, we continue to anticipate overall performance for 2019 to be in line with our expectations.

Β 

For further information, contact:

Β 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

Β 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
AGMLIFIAELITIIA
Date   Source Headline
24th Nov 20223:25 pmRNSDirector/PDMR Shareholding
14th Nov 20229:29 amRNSDirector/PDMR Shareholding
11th Oct 20224:21 pmRNSDirector/PDMR Shareholding
10th Oct 20224:36 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:24 pmRNSDirector/PDMR Shareholding
1st Sep 202210:07 amRNSTotal Voting Rights
31st Aug 202210:00 amRNSDirector/PDMR Shareholding
16th Aug 20223:33 pmRNSBlock listing Interim Review
16th Aug 202211:12 amRNSDirector/PDMR Shareholding
11th Aug 20224:12 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSHalf-year Report
12th Jul 20223:34 pmRNSDirector/PDMR Shareholding
1st Jul 20223:56 pmRNSDirector/PDMR Shareholding
1st Jul 202210:00 amRNSTotal Voting Rights
20th Jun 20224:33 pmRNSHolding(s) in Company
17th Jun 20227:29 amRNSHolding(s) in Company
15th Jun 202212:00 pmRNSHolding(s) in Company
10th Jun 20223:46 pmRNSHolding(s) in Company
1st Jun 20222:22 pmRNSHolding(s) in Company
1st Jun 202210:00 amRNSTotal Voting Rights
31st May 20222:53 pmRNSHolding(s) in Company
27th May 202210:00 amRNSHolding(s) in Company
26th May 20223:56 pmRNSDirector/PDMR Shareholding
17th May 20225:17 pmRNSHolding(s) in Company
17th May 20225:12 pmRNSHolding(s) in Company
11th May 20225:44 pmRNSDirector/PDMR Shareholding
11th May 20222:22 pmRNSResult of AGM
11th May 20229:56 amRNSAGM Statement
3rd May 20227:00 amRNSTotal Voting Rights
27th Apr 20224:13 pmRNSDirectors Remuneration Report - Clarification
21st Apr 20224:57 pmRNSDirector/PDMR Shareholding
21st Apr 20224:44 pmRNSHolding(s) in Company
12th Apr 20222:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:28 pmRNSAnnual Report and AGM Notice
1st Apr 202210:00 amRNSTotal Voting Rights
14th Mar 202210:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSFinal Results
3rd Mar 202211:00 amRNSTotal Voting Rights
15th Feb 202211:00 amRNSBlock listing Interim Review
14th Feb 202212:00 pmRNSDirector/PDMR Shareholding
1st Feb 202210:27 amRNSTotal Voting Rights
21st Jan 202210:00 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSYear End Trading Update
11th Jan 20223:04 pmRNSDirector/PDMR Shareholding
4th Jan 202211:19 amRNSTotal Voting Rights
31st Dec 202110:06 amRNSSavills IM & Samsung Life Investment Alliance
13th Dec 202112:38 pmRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSTotal Voting Rights
25th Nov 202112:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.